Tiny tots, big data: gadopiclenol safety in infants

NCT ID NCT05590884

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times

Summary

This study looked at how the contrast agent gadopiclenol is processed in the bodies of 36 infants up to 23 months old who needed an MRI. The goal was to measure drug levels and safety, not to treat any disease. Results help doctors use the right dose for young children.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cincinnatti Childrens Hospital

    Cincinnati, Ohio, 45229, United States

  • Instytut "Pomnik - Centrum Zdrowia Dziecka"

    Warsaw, Poland

  • Instytut Centrum Zdrowia Matki Polki

    Lodz, Poland

  • Kliniczny Szpital Wojewodzki Nr 2 im. Sw. Jadwigi Krolowej

    Rzeszów, Poland

  • Medical University of South Carolina

    Charleston, South Carolina, 29425-8908, United States

  • Országos Idegtudományi Intézet

    Budapest, Hungary

  • Semmelweis Egyetem

    Budapest, 1094, Hungary

  • Szpital Uniwersytecki nr 1 im. dr Antoniego Jurasza

    Bydgoszcz, Poland

  • University of Debrecen Clinical Center Pediatric Department

    Debrecen, Hungary

  • Uniwersytecki Szpital Dzieciecy

    Lublin, Poland

  • Uniwersyteckie Centrum Kliniczne Warszawskiego

    Warsaw, 02-091, Poland

Conditions

Explore the condition pages connected to this study.